The treatment also upregulates Pdcd1 expression and other checkpoint molecules, and PD-1 blockade enhanced the efficacy and persistence of the anti-tumor effects by increasing the proportion and intensity of induced memory CD8+ T cells. The gene discussed is PDCD1; the disease is neoplasm.